These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 27220316)

  • 1. A Founder Effect of c.257 + 2T > C Mutation in NCF2 Gene Underlies Severe Chronic Granulomatous Disease in Eleven Patients.
    Ben-Farhat K; Ben-Mustapha I; Ben-Ali M; Rouault K; Hamami S; Mekki N; Ben-Chehida A; Larguèche B; Fitouri Z; Abdelmoula S; Khemiri M; Guediche MN; Boukthir S; Barsaoui S; Chemli J; Barbouche MR
    J Clin Immunol; 2016 Aug; 36(6):547-54. PubMed ID: 27220316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second Report of Chronic Granulomatous Disease in Jordan: Clinical and Genetic Description of 31 Patients From 21 Different Families, Including Families From Lybia and Iraq.
    Bakri FG; Mollin M; Beaumel S; Vigne B; Roux-Buisson N; Al-Wahadneh AM; Alzyoud RM; Hayajneh WA; Daoud AK; Shukair MEA; Karadshe MF; Sarhan MM; Al-Ramahi JAW; Fauré J; Rendu J; Stasia MJ
    Front Immunol; 2021; 12():639226. PubMed ID: 33746979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Granulomatous Disease Due to Neutrophil Cytosolic Factor (NCF2) Gene Mutations in Three Unrelated Families.
    Vignesh P; Rawat A; Kumar A; Suri D; Gupta A; Lau YL; Chan KW; Singh S
    J Clin Immunol; 2017 Feb; 37(2):109-112. PubMed ID: 28035544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.
    Köker MY; Camcıoğlu Y; van Leeuwen K; Kılıç SŞ; Barlan I; Yılmaz M; Metin A; de Boer M; Avcılar H; Patıroğlu T; Yıldıran A; Yeğin O; Tezcan I; Sanal Ö; Roos D
    J Allergy Clin Immunol; 2013 Nov; 132(5):1156-1163.e5. PubMed ID: 23910690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia.
    El Kares R; Barbouche MR; Elloumi-Zghal H; Bejaoui M; Chemli J; Mellouli F; Tebib N; Abdelmoula MS; Boukthir S; Fitouri Z; M'Rad S; Bouslama K; Touiri H; Abdelhak S; Dellagi MK
    J Hum Genet; 2006; 51(10):887-895. PubMed ID: 16937026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel NCF2 Mutation Causing Chronic Granulomatous Disease.
    Roth IL; Salamon P; Freund T; Gadot YB; Baron S; Hershkovitz T; Shefler I; Hanna S; Confino-Cohen R; Bentur L; Hagin D
    J Clin Immunol; 2020 Oct; 40(7):977-986. PubMed ID: 32666379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four different NCF2 mutations in six families from Turkey and an overview of NCF2 gene mutations.
    Köker MY; Sanal O; van Leeuwen K; de Boer M; Metin A; Patiroğlu T; Ozgür TT; Tezcan I; Roos D
    Eur J Clin Invest; 2009 Oct; 39(10):942-51. PubMed ID: 19624736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Characteristics, Infectious, and Noninfectious Manifestations of 32 Patients with Chronic Granulomatous Disease.
    Aygun D; Koker MY; Nepesov S; Koker N; van Leeuwen K; de Boer M; Kıykım A; Ozsoy S; Cokugras H; Kuijpers T; Roos D; Camcıoglu Y
    Int Arch Allergy Immunol; 2020; 181(7):540-550. PubMed ID: 32512560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic granulamatous disease: Two decades of experience from a paediatric immunology unit in a country with high rate of consangineous marriages.
    Kutukculer N; Aykut A; Karaca NE; Durmaz A; Aksu G; Genel F; Pariltay E; Cogulu Ö; Azarsız E
    Scand J Immunol; 2019 Feb; 89(2):e12737. PubMed ID: 30506560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approach to Molecular Diagnosis of Chronic Granulomatous Disease (CGD): an Experience from a Large Cohort of 90 Indian Patients.
    Kulkarni M; Hule G; de Boer M; van Leeuwen K; Kambli P; Aluri J; Gupta M; Dalvi A; Mhatre S; Taur P; Desai M; Madkaikar M
    J Clin Immunol; 2018 Nov; 38(8):898-916. PubMed ID: 30470980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and molecular findings of chronic granulomatous disease in Oman: family studies.
    Al-Zadjali S; Al-Tamemi S; Elnour I; AlKindi S; Lapoumeroulie C; Al-Maamari S; Pathare A; Dennison D; Krishnamoorthy R
    Clin Genet; 2015 Feb; 87(2):185-9. PubMed ID: 24446915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocyte/macrophage-specific NADPH oxidase contributes to antimicrobial host defense in X-CGD.
    Okura Y; Yamada M; Kuribayashi F; Kobayashi I; Ariga T
    J Clin Immunol; 2015 Feb; 35(2):158-67. PubMed ID: 25666294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.
    Jirapongsananuruk O; Malech HL; Kuhns DB; Niemela JE; Brown MR; Anderson-Cohen M; Fleisher TA
    J Allergy Clin Immunol; 2003 Feb; 111(2):374-9. PubMed ID: 12589359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular diagnosis of X-linked chronic granulomatous disease in Iran.
    Teimourian S; Rezvani Z; Badalzadeh M; Kannengiesser C; Mansouri D; Movahedi M; Zomorodian E; Parvaneh N; Mamishi S; Pourpak Z; Moin M
    Int J Hematol; 2008 May; 87(4):398-404. PubMed ID: 18322777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations of chronic granulomatous disease in Turkish families.
    Köker MY; Sanal O; De Boer M; Tezcan I; Metin A; Ersoy F; Roos D
    Eur J Clin Invest; 2007 Jul; 37(7):589-95. PubMed ID: 17576211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.
    Bakri FG; Martel C; Khuri-Bulos N; Mahafzah A; El-Khateeb MS; Al-Wahadneh AM; Hayajneh WA; Hamamy HA; Maquet E; Molin M; Stasia MJ
    J Clin Immunol; 2009 Mar; 29(2):215-30. PubMed ID: 18773283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox.
    Patiño PJ; Rae J; Noack D; Erickson R; Ding J; de Olarte DG; Curnutte JT
    Blood; 1999 Oct; 94(7):2505-14. PubMed ID: 10498624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic granulomatous disease in Morocco: genetic, immunological, and clinical features of 12 patients from 10 kindreds.
    Baba LA; Ailal F; El Hafidi N; Hubeau M; Jabot-Hanin F; Benajiba N; Aadam Z; Conti F; Deswarte C; Jeddane L; Aglaguel A; El Maataoui O; Tissent A; Mahraoui C; Najib J; Martinez-Barricarte R; Abel L; Habti N; Saile R; Casanova JL; Bustamante J; Salih Alj H; Bousfiha AA
    J Clin Immunol; 2014 May; 34(4):452-8. PubMed ID: 24596025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The three CYBA variants (rs4673, rs1049254 and rs1049255) are benign: new evidence from a patient with CGD.
    Sun J; Wen M; Wang Y; Liu D; Ying W; Wang X
    BMC Med Genet; 2017 Nov; 18(1):127. PubMed ID: 29132304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mutations in CYBB Gene Cause X-linked chronic Granulomatous Disease in Pakistani patients.
    Gul I; Khan TA; Akbar NU; Gul N; Ali R; Khan SN
    Ital J Pediatr; 2023 Aug; 49(1):95. PubMed ID: 37533075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.